
The family of a woman who killed herself while taking Pfizer’s epilepsy drug Neurotonin has dropped their lawsuit in the midst of the trial. The decision to drop the suit was apparently made after an anonymous donor offered to put money into a trust for the woman’s 10 year old daughter.
The woman, Susan Bulger, was taking Neurotonin to combat mood swings and arthritis pain when she killed herself. Pfizer lawyers argued that Bulger had a history of drug abuse and had tried to kill herself six times before she was successful.
Neurotonin is not labeled for treating mood swings or arthritis pain, but is often used that way by doctors prescribing it for off-label use. The Bulgers also contended that Pfizer did not warn the public that the drug could increase a patient’s risk of suicide until they were forced to do so by the government.
The Bulger’s dropped lawsuit isn’t the last that Pfizer will hear from families of patients who killed or tried to kill themselves while taking Neurotonin. This was the first of about 1,200 Neurotonin suits claiming that Pfizer should have warned patients and doctors that the drug could increase suicidal thoughts. The next Neurotonin case will begin in Boston federal court in March.
In 2004 the company’s Warner-Lambert unit paid $430 million to settle off-label Neurotonin marketing allegations made by the U.S. Justice Department.
Read More About First Pfizer lawsuit over Neurotonin suicide dropped...
Tavss Fletcher
RBC Centura
555 East Main Street
14th Floor
Norfolk, VA 23510
Phone: 757.625.1214
Fax: 757.622.7295
Get Directions